Healios K.K.

General ticker "HLOSF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $267.9M (TTM average)

Healios K.K. follows the US Stock Market performance with the rate: 32.7%.

Estimated limits based on current volatility of 0.1%: low 2.50$, high 2.51$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.97$, 2.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.90$, 2.26$]

Similar symbols

Short-term HLOSF quotes

Long-term HLOSF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue ¥90.00MM ¥121.00MM ¥560.00MM
Operating Expenses ¥5,269.00MM ¥3,500.00MM ¥3,403.00MM
Operating Income ¥-5,179.00MM ¥-3,379.00MM ¥-2,843.00MM
Non-Operating Income ¥-151.00MM ¥-247.00MM ¥-1,218.00MM
Interest Expense ¥500.00MM ¥704.00MM ¥1,589.00MM
R&D Expense ¥3,808.00MM ¥2,304.00MM ¥1,960.00MM
Income(Loss) ¥-5,330.00MM ¥-3,626.00MM ¥-4,061.00MM
Taxes ¥0.00MM ¥187.00MM ¥166.00MM
Profit(Loss)* ¥-5,170.00MM ¥-3,823.00MM ¥-4,235.00MM
Stockholders Equity ¥4,382.00MM ¥3,856.00MM ¥2,063.00MM
Assets ¥15,033.00MM ¥15,155.00MM ¥14,191.00MM
Operating Cash Flow ¥-4,601.00MM ¥-2,822.00MM ¥-1,817.00MM
Capital expenditure ¥262.00MM ¥28.00MM ¥307.00MM
Investing Cash Flow ¥-909.00MM ¥-1,121.00MM ¥-1,418.00MM
Financing Cash Flow ¥-2,502.00MM ¥3,337.00MM ¥77.00MM
Earnings Per Share** ¥-90.69 ¥-56.22 ¥-47.87

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.